Innovator’s Pitch Challenge

Access Vascular was founded to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis. Taking a foundationally different approach to thrombus reduction, the company manufactures intravenous catheters from a hydrophilic material which absorbs and retains significant amounts of water. Mimicking the body’s natural chemistry, Access Vascular catheters are designed to evade the foreign body response and complications that come with it.

Our cleared products are HydroPICC and HydroMID.